151 related articles for article (PubMed ID: 21165400)
1. Antiviral activity of Anaferon (pediatric formulation) in mice infected with pandemic influenza virus A(H1N1/09).
Shishkina LN; Skarnovich MO; Kabanov AS; Sergeev AA; Olkin SE; Tarasov SA; Belopolskaya MV; Sergeeva SA; Epstein OI; Malkova EM; Stavsky EA; Drozdov IG
Bull Exp Biol Med; 2010 Oct; 149(5):612-4. PubMed ID: 21165400
[TBL] [Abstract][Full Text] [Related]
2. [Study of efficacy of anaferon pediatric in mice infected by pandemic influenza virus A(H1N1/09)v].
Shishkina LI; Skarnovich MO; Kabanov AS; Sergeev AA; Tarasov SA; Sergeeva SA; Épshteĭn ; Malkova EM; Stavskiĭ EA; Drozdov IG
Zh Mikrobiol Epidemiol Immunobiol; 2011; (1):83-6. PubMed ID: 21446173
[TBL] [Abstract][Full Text] [Related]
3. [In vivo efficacy of Ingavirin against pandemic A (H1N1/09)v influenza virus].
Shishkina LN; Nebol'sin VE; Skarnovich MO; Kabanov AS; Sergeev AA; Erdyneeva UB; Serova OA; Demina OK; Agafonov AP; Stavskiĭ EA; Drozdov IG
Antibiot Khimioter; 2010; 55(5-6):32-5. PubMed ID: 21033472
[TBL] [Abstract][Full Text] [Related]
4. Study of efficiency of therapeutic and preventive anaferon (pediatric formulation) in mice with influenza infection.
Shishkina LN; Sergeev AN; Kabanov AS; Skarnovich MO; Evtin NK; Mazurkova NA; Sergeev AA; Belopolskaya MV; Kheyfets IA; Dugina JL; Tarasov SA; Sergeeva SA; Epstein OI
Bull Exp Biol Med; 2008 Dec; 146(6):763-5. PubMed ID: 19513378
[TBL] [Abstract][Full Text] [Related]
5. Activities of JNJ63623872 and oseltamivir against influenza A H1N1pdm and H3N2 virus infections in mice.
Smee DF; Barnard DL; Jones SM
Antiviral Res; 2016 Dec; 136():45-50. PubMed ID: 27771390
[TBL] [Abstract][Full Text] [Related]
6. A single intramuscular injection of neuraminidase inhibitor peramivir demonstrates antiviral activity against novel pandemic A/California/04/2009 (H1N1) influenza virus infection in mice.
Bantia S; Kellogg D; Parker C; Upshaw R; Ilyushina NA; Babu YS
Antiviral Res; 2011 Apr; 90(1):17-21. PubMed ID: 21316393
[TBL] [Abstract][Full Text] [Related]
7. Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1 feeding enhances humoral immune responses, which are suppressed by the antiviral neuraminidase inhibitor oseltamivir in influenza A virus-infected mice.
Takahashi E; Sawabuchi T; Kimoto T; Sakai S; Kido H
J Dairy Sci; 2019 Nov; 102(11):9559-9569. PubMed ID: 31495632
[TBL] [Abstract][Full Text] [Related]
8. The combination of oseltamivir with azithromycin does not show additional benefits over oseltamivir monotherapy in mice infected with influenza A(H1N1)pdm2009 virus.
Fage C; Pizzorno A; Rhéaume C; Abed Y; Boivin G
J Med Virol; 2017 Dec; 89(12):2239-2243. PubMed ID: 28792077
[TBL] [Abstract][Full Text] [Related]
9. Anti-influenza virus activity of propolis in vitro and its efficacy against influenza infection in mice.
Shimizu T; Hino A; Tsutsumi A; Park YK; Watanabe W; Kurokawa M
Antivir Chem Chemother; 2008; 19(1):7-13. PubMed ID: 18610553
[TBL] [Abstract][Full Text] [Related]
10. Oseltamivir-zanamivir combination therapy is not superior to zanamivir monotherapy in mice infected with influenza A(H3N2) and A(H1N1)pdm09 viruses.
Pizzorno A; Abed Y; Rhéaume C; Boivin G
Antiviral Res; 2014 May; 105():54-8. PubMed ID: 24583158
[TBL] [Abstract][Full Text] [Related]
11. Combination Therapy with Oseltamivir and Favipiravir Delays Mortality but Does Not Prevent Oseltamivir Resistance in Immunodeficient Mice Infected with Pandemic A(H1N1) Influenza Virus.
Baz M; Carbonneau J; Rhéaume C; Cavanagh MH; Boivin G
Viruses; 2018 Nov; 10(11):. PubMed ID: 30400276
[TBL] [Abstract][Full Text] [Related]
12. [Protective activity of Ingavirin in experimental lethal influenza due to pandemic influenza virus A (H1N1)v in albino mice].
Zarubaev VV; Garshinina AV; Kalinina NA; Shtro AA; Beliaevskaia SV; Nebol'sin VE; Kiselev OI
Antibiot Khimioter; 2010; 55(5-6):24-31. PubMed ID: 21033471
[TBL] [Abstract][Full Text] [Related]
13. Activity of ergoferon against lethal influenza A (H3N2) virus infection in mice.
Skarnovich MA; Emelyanova AG; Petrova NV; Borshcheva AA; Gorbunov EA; Mazurkov OY; Skarnovich MO; Tarasov SA; Shishkina LN; Epstein OI
Antivir Ther; 2017; 22(4):345-351. PubMed ID: 27924780
[TBL] [Abstract][Full Text] [Related]
14. Activities of oseltamivir and ribavirin used alone and in combination against infections in mice with recent isolates of influenza A (H1N1) and B viruses.
Smee DF; Wong MH; Bailey KW; Sidwell RW
Antivir Chem Chemother; 2006; 17(4):185-92. PubMed ID: 17066897
[TBL] [Abstract][Full Text] [Related]
15. The effect of intravenous peramivir, compared with oral oseltamivir, on the outcome of post-influenza pneumococcal pneumonia in mice.
Tanaka A; Nakamura S; Seki M; Iwanaga N; Kajihara T; Kitano M; Homma T; Kurihara S; Imamura Y; Miyazaki T; Izumikawa K; Kakeya H; Yanagihara K; Kohno S
Antivir Ther; 2015; 20(1):11-9. PubMed ID: 24517996
[TBL] [Abstract][Full Text] [Related]
16. The effect of P38 MAP kinase inhibition in a mouse model of influenza.
Growcott EJ; Bamba D; Galarneau JR; Leonard VHJ; Schul W; Stein D; Osborne CS
J Med Microbiol; 2018 Mar; 67(3):452-462. PubMed ID: 29458547
[TBL] [Abstract][Full Text] [Related]
17. Dose-dependent antiviral activity of released-active form of antibodies to interferon-gamma against influenza A/California/07/09(H1N1) in murine model.
Don ЕS; Emelyanova AG; Yakovleva NN; Petrova NV; Nikiforova MV; Gorbunov EA; Tarasov SА; Morozov SG; Epstein ОI
J Med Virol; 2017 May; 89(5):759-766. PubMed ID: 27769099
[TBL] [Abstract][Full Text] [Related]
18. Anti-IFN-γ therapy alleviates acute lung injury induced by severe influenza A (H1N1) pdm09 infection in mice.
Liu B; Bao L; Wang L; Li F; Wen M; Li H; Deng W; Zhang X; Cao B
J Microbiol Immunol Infect; 2021 Jun; 54(3):396-403. PubMed ID: 31780358
[TBL] [Abstract][Full Text] [Related]
19. Activity of ultra-low doses of antibodies to gamma-interferon against lethal influenza A(H1N1)2009 virus infection in mice.
Tarasov SA; Zarubaev VV; Gorbunov EA; Sergeeva SA; Epstein OI
Antiviral Res; 2012 Feb; 93(2):219-224. PubMed ID: 22178245
[TBL] [Abstract][Full Text] [Related]
20. Reduction of Neuraminidase Activity Exacerbates Disease in 2009 Pandemic Influenza Virus-Infected Mice.
Ranadheera C; Hagan MW; Leung A; Collignon B; Cutts T; Theriault S; Embury-Hyatt C; Kobasa D
J Virol; 2016 Nov; 90(21):9931-9941. PubMed ID: 27558428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
